KINRIX

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 58160-812
  • Package NDC 58160-812-52
  • Application number BLA125260
  • SPL ID 0066d4bd-89fc-4bf7-80ce-4d9c49f59244

What the source publishes

Labeler
GlaxoSmithKline Biologicals SA
Active ingredients
Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine
Form
INJECTION, SUSPENSION
Routes
INTRAMUSCULAR
Administrative status
present-in-source-snapshot
Marketing status
BLA
Product type
VACCINE

Names this record is found by

Complete source data
us:fda:ndc:58160-812_0066d4bd-89fc-4bf7-80ce-4d9c49f59244
{
  "name": "KINRIX",
  "splId": "0066d4bd-89fc-4bf7-80ce-4d9c49f59244",
  "labels": [],
  "routes": [
    "INTRAMUSCULAR"
  ],
  "labeler": "GlaxoSmithKline Biologicals SA",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "10 SYRINGE in 1 CARTON (58160-812-52)  / .5 mL in 1 SYRINGE (58160-812-43)",
      "package_ndc": "58160-812-52",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20080709"
    }
  ],
  "productId": "58160-812_0066d4bd-89fc-4bf7-80ce-4d9c49f59244",
  "useDomain": "unknown",
  "dosageForm": "INJECTION, SUSPENSION",
  "productNdc": "58160-812",
  "deaSchedule": null,
  "genericName": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine",
  "productType": "VACCINE",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "CORYNEBACTERIUM DIPHTHERIAE TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "25 [iU]/.5mL"
    },
    {
      "name": "CLOSTRIDIUM TETANI TOXOID ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "10 [iU]/.5mL"
    },
    {
      "name": "BORDETELLA PERTUSSIS FILAMENTOUS HEMAGGLUTININ ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "25 [iU]/.5mL"
    },
    {
      "name": "BORDETELLA PERTUSSIS PERTACTIN ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "8 ug/.5mL"
    },
    {
      "name": "BORDETELLA PERTUSSIS TOXOID ANTIGEN (FORMALDEHYDE, GLUTARALDEHYDE INACTIVATED)",
      "strength": "25 ug/.5mL"
    },
    {
      "name": "POLIOVIRUS TYPE 1 ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "40 [iU]/.5mL"
    },
    {
      "name": "POLIOVIRUS TYPE 2 ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "8 [iU]/.5mL"
    },
    {
      "name": "POLIOVIRUS TYPE 3 ANTIGEN (FORMALDEHYDE INACTIVATED)",
      "strength": "32 [iU]/.5mL"
    }
  ],
  "applicationNumber": "BLA125260",
  "marketingCategory": "BLA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20080709",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "unknown",
  "harmonizedIdentifiers": {},
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:58160-812_0066d4bd-89fc-4bf7-80ce-4d9c49f59244"